Sep 2026· Gut microbes· Vol 18· 0 citations· 64 references
Medicine
TL;DR
Together, these findings uncover a cross-kingdom vesicle communication axis whereby fungal EV exposure remodels the molecular and functional properties of gut microbial vesicles, accompanied by enhanced lysosomal homeostasis and protection against intestinal inflammation.
Abstract
Abstract Extracellular vesicles (EVs) are emerging mediators of intercellular and interkingdom communication. While bacterial EVs directly modulate host health, whether exogenous vesicles can reprogram gut microbial vesiculation and bioactivity remains unclear. Using a defined in vitro conditioning system, ScEV exposure altered EV production by Lactobacillus rhamnosus, generating ScEV-conditioned L. rhamnosus vesicles (ScEV-LrEVs). Comparative proteomics and lipidomics revealed extensive remodeling of vesicle cargo, including ~60-fold enrichment of hydroxylated ceramide Cer(t18:0/24:0(2OH)) in ScEV-LrEVs. Functionally, ScEV-LrEVs showed enhanced anti-inflammatory activity in LPS-stimulated macrophages, accompanied by improved lysosomal function and coordinated changes in mTOR-TFEB-related lysosome-autophagy markers. In a DSS-induced colitis model, ScEV-LrEVs alleviated mucosal injury, reduced immune-cell infiltration, and reinforced epithelial barrier integrity, accompanied by restoration of lysosomal function and coordinated changes in mTOR-TFEB-related markers. Ceramide-enriched EVs partially recapitulated the anti-inflammatory and lysosome-restorative activity of ScEV-LrEVs. Together, these findings uncover a cross-kingdom vesicle communication axis whereby fungal EV exposure remodels the molecular and functional properties of gut microbial vesicles, accompanied by enhanced lysosomal homeostasis and protection against intestinal inflammation.
This article addresses extracellular vesicles derived from lactic acid bacteria (LAB-EVs), which have become fundamental mediators of host-microbe communication, yielding new insights about the molecular mechanisms underlying probiotic and postbiotic activity. The review integrates current evidence on the biogenesis, s...
Maria Júlia Borges Mello, B. R. Fonseca, Gabriela Coutinho Saceloti et al.· Probiotics and Antimicrobial...· 0 citations
Intestinal barrier dysfunction is a hallmark of inflammatory bowel disease (IBD), yet effective therapies remain limited, and the mechanisms of probiotic-derived extracellular vesicles (EVs) are poorly understood. Using complementary cell, murine, and intestinal organoid models, we investigated the protective effects o...
Ying-Jie Huang, La Xi, Bin Yu et al.· Journal of Agricultural and...· 0 citations
This review synthesizes recent advances in LAB-EV biology and outlines the considerations necessary to harness these nano-couriers as valuable tools in modern biomedicine and food science.
Yue Liu· Current Opinion in Microbiol...· 0 citations
Summary Amniotic epithelial cells (AECs) exert potent paracrine immunoregulatory functions, yet whether inflammatory cues enhance the biological activity of their extracellular vesicles (EVs) remains unclear. To address this question, we characterized the secretome of ovine AECs under basal and lipopolysaccharide (LPS)...
G. Prencipe, A. Cerveró-Varona, A. Peserico et al.· iScience· 0 citations
Extracellular vesicles (EVs) have been shown to be key regulators of intestinal homeostasis and inflammatory responses, offering new insights into the pathogenesis of inflammatory bowel disease (IBD) and the development of targeted therapeutic strategies. EVs in the intestine can be secreted by intestinal epithelial ce...
Yiyi Lv, Qian Yang, Xi-Xi Cai et al.· Autoimmunity Reviews· 0 citations
The gut-liver axis is a central conduit through which intestinal immunity and metabolism regulate liver health. Although gut probiotics such as Parabacteroides distasonis (P. distasonis) and their postbiotics show promise for treating related disorders, safety and stability concerns and inconsistent efficacy limit thei...